A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity
Author:
Wu Jin-YuanORCID, Zhang Wei, Pu Jing, Liu Yan, Huang Li-Li, Zhou Yan, Gao Jia-Mei, Tan Jie-Bing, Liu Xin-Ling, Yang Jing, Lin Xiao-Chen, Feng Guang-Wei, Yin Na, Chen Rong, Hu Xiao-Qing, Yi Shan, Ye Jun, Kuang Xiang-Jing, Wang Yan, Zhang Guang-Ming, Sun Mao-Sheng, Wang Yan-Xia, Hu Zhong-Yu, Yang Jing-Si, Li Hong-Jun
|
|